{"id":"W4392631817","doi":"10.1136/ijgc-2024-esgo.25","title":"462 Progression-free survival 2-progression-free survival 1 in patients with primary advanced/recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial","year":2024,"lang":"en","type":"article","venue":"International Journal of Gynecological Cancer","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Chemotherapy; Endometrial cancer; Oncology; Progression-free survival; Medicine; Internal medicine; Overall survival; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001685898,0.0010221,0.002753169,0.0002859595,0.0002708474,0.001000534,0.0004494146,0.001008899,0.003212739],"category_scores_gemma":[0.001209415,0.000371551,0.00353836,0.0002777223,0.0006298207,0.0009037885,0.0004103473,0.002707688,0.0004004204],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000622205,"about_ca_system_score_gemma":0.0007011336,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007134631,"about_ca_topic_score_gemma":0.002375949,"domain_scores_codex":[0.9991798,0.0004687231,0.00003927326,0.0001325633,0.00004471165,0.0001348864],"domain_scores_gemma":[0.9995426,0.0001426055,0.00009966658,0.00004138405,0.00002025294,0.0001536039],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9547555,0.001354561,0.004921174,0.00089814,0.003952122,0.00007458368,0.00004933462,0.001671739,0.003061076,0.0002097796,0.001299076,0.02775294],"study_design_scores_gemma":[0.7362315,0.1954837,0.04903497,0.0002645813,0.009483712,0.0002319771,0.00009248864,0.00251959,0.001432379,0.001313902,0.003839056,0.00007222558],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9815999,0.01213869,0.0003373868,0.0009316285,0.0004884279,0.0003770497,0.00113697,0.00004828054,0.002941655],"genre_scores_gemma":[0.9929293,0.002498702,0.0003215109,0.0006928269,0.0003229644,0.0002909235,0.001299332,0.00001348211,0.001630976],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003212739,"threshold_uncertainty_score":0.01074773,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02582157677078276,"score_gpt":0.3367139886153397,"score_spread":0.310892411844557,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}